Editorial by Susan Marlin, President & CEO, Clinical Trials Ontario
Ontario has long been an attractive jurisdiction for conducting high-quality clinical trials. We have all the right ingredients: world-class talent, cutting-edge infrastructure, a diverse patient population and programs to support industry. But within the last decade, Ontario has hit a new stride, becoming a hive of clinical trials activity that outranks other global jurisdictions.